| HOME >> BIOLOGY >> TECHNOLOGY |
ial which may ultimately define how drugs are developed in the future, and I am looking forward to working closely with Sutro's management as a scientific advisor."
Prof. Swartz, a leading expert in the field of cell-free protein synthesis, is a director and founder of Sutro Biopharma. He holds the James H. Clark Professorship in the School of Engineering at Stanford University and is a professor in the departments of bioengineering and chemical engineering. Prof. Swartz is a member of the National Academy of Engineering with over twenty years of industrial experience at Eli Lilly and Genentech prior to joining Stanford in 1998. He received his undergraduate degree in chemical engineering from the South Dakota School of Mines and his graduate degree from the Massachusetts Institute of Technology. Prof. Swartz is an author and a co-author on numerous scientific publications dealing with protein expression and advancement of cell-free protein production technology.
"I am delighted to expand my involvement with Sutro through the appointment as scientific advisor," said Prof. Swartz. "Sutro has made tremendous progress within the past year, and the scientific advisory board will be tasked with helping to guide Sutro's management as they work to expand the company's proprietary pipeline as well as the projects with current and new partners."
About Sutro Biopharma
Sutro Biopharma, located in South San Francisco, is developing a new generation of multi-functional antibody drug conjugate combination therapeutics and bifunctional antibody-based therapeutics for targeted cancer therapies. These therapeutics will significantly extend the clinical impact of current oncology therapeutic approaches, and are beyond what can be envisioned with current (cell-based) expression technologies. Sutro's biochemical synthesis technology, which underpins these therapeutics, allows the rapid and systematic exploration of many protein drug variants
'/>"/>
| SOURCE Sutro Biopharma Copyright©2010 PR Newswire. All rights reserved |
Related biology technology :
1. Sutro Biopharma to Present its Biochemical Protein Synthesis Technology at BioProduction Conference 2011 in Berlin
2. Sutro Biopharma Forges Partnership with Pfizer for Discovery, Development and Commercialization of Novel Peptide-Based Therapeutics
3. AnaptysBio Announces New Strategic Antibody Discovery
4. Tengion Announces Relocation of Corporate Headquarters to Current Facility in Winston-Salem, North Carolina
5. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
6. AtheroNova Announces a New Board Member
7. RSB Spine, LLC Announces 2011 Revenue Growth
8. ThermoGenesis Announces Approval of AXP® by India Ministry of Health
9. Telik Announces Presentation and Webcast at 5th Annual OneMedForum Conference
10. Verify Brand™ Announces the Release of VB Enterprise 4.0
11. Sinovac Announces Resignation of Chup Hung Mok from Board of Directors
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |